Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ATOS Atossa Therapeutics Inc

0.0305 (4.14%)
Dec 09 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Atossa Therapeutics Inc ATOS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0305 4.14% 0.7668 00:00:07
Open Price Low Price High Price Close Price Prev Close
0.74 0.72 0.7669 0.7532 0.7363
more quote information »

Recent News

Date Time Source Heading
12/04/202308:30GLOBEAtossa Therapeutics Announces the Appointment of Arezoo..
11/20/202308:30GLOBEAtossa Therapeutics Announces Full Enrollment of Phase 2..
11/15/202317:03EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
11/15/202316:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/15/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202309:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202309:00EDGAR2Form 8-K - Current report
11/13/202309:00GLOBEAtossa Therapeutics Announces Third Quarter 2023 Financial..
11/09/202309:00EDGAR2Form 8-K - Current report
11/09/202309:00GLOBEAtossa Therapeutics Appoints Financial Executive Jonathan..
10/30/202313:00PRNUSQuantum Leap Healthcare Collaborative Initiates Landmark..
10/16/202316:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/11/202308:30PRNUSFast-food consumption by adolescent girls may sow the seeds..
10/06/202316:00EDGAR2Form 8-K - Current report
9/28/202316:28EDGAR2Form 8-K - Current report
9/18/202308:30GLOBEAtossa to Present at Cantor Fitzgerald Global Healthcare..
8/14/202308:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202308:30EDGAR2Form 8-K - Current report
8/14/202308:30GLOBEAtossa Therapeutics Announces Second Quarter 2023 Financial..
8/08/202309:00GLOBEAtossa Therapeutics to Provide Business Update and Report..
7/20/202309:15GLOBEAtossa Therapeutics Receives Approval from Health Canada to..
7/13/202316:20EDGAR2Form 8-K - Current report
7/13/202316:15GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
7/10/202309:15GLOBEAtossa Therapeutics Provides Enrollment Update for Ongoing..
7/06/202309:15GLOBEAtossa Therapeutics Announces Sponsored Research Agreement..
6/28/202309:15PRNUSAtossa Therapeutics and Quantum Leap Healthcare Provide..
6/28/202309:01EDGAR2Form 8-K - Current report
6/27/202309:15GLOBEAtossa Therapeutics Announces $10M Stock Repurchase Program
6/22/202316:15GLOBEAtossa Therapeutics Announces Sponsorship of Are You Dense..
6/21/202310:13GLOBEAtossa Therapeutics Granted Additional Patent Protection for..
6/14/202309:15GLOBEAtossa to Participate in Fireside Chat at Healthcare Virtual..
6/12/202309:15GLOBEAtossa Completes Enrollment of Pharmacokinetic Run-In Cohort..
6/01/202309:10GLOBEAtossa Appoints Life Sciences Financial and Operations..
5/23/202307:00GLOBESocietal CDMO Enters Agreement With Atossa Therapeutics to..
5/15/202309:10GLOBEAtossa Therapeutics Announces First Quarter 2023 Financial..
5/11/202309:00PRNUSPhysician-Scientist Dr. Steven Quay Provides Recommendations..
5/09/202309:15GLOBEAtossa to Present a Trial in Progress Poster on its..
4/27/202309:15GLOBEAtossa Therapeutics to Participate in Tribe Public’s Webinar..
3/22/202316:05GLOBEAtossa Therapeutics Announces Year-End 2022 Financial..
3/21/202313:19PRNUSAtossa Therapeutics and Quantum Leap Healthcare Announce New..
3/21/202309:15GLOBEAtossa Therapeutics and Quantum Leap Healthcare Announce New..
3/15/202309:25GLOBEAtossa to Present at the Sidoti Small-Cap Virtual Conference
2/23/202309:15GLOBEAtossa Doses First Patient in Phase 2 Neoadjuvant Clinical..
2/13/202309:15GLOBEAtossa Therapeutics Further Strengthens Intellectual..
1/25/202309:15GLOBEAtossa Therapeutics Issues Letter to Shareholders

Your Recent History

Delayed Upgrade Clock